Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Cancer Medicine
|
January 10, 2024
Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis
Yangyang Li, Wendao Liu, Junwei Chen, et al.
Journal of Hepatocellular Carcinoma
|
July 13, 2026
SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling
Hongyu Wang, Guojun Liang, Ting Liu, et al.
Genes
|
July 27, 2022
Drug-Target Network Study Reveals the Core Target-Protein Interactions of Various COVID-19 Treatments
Yulin Dai, Hui Yu, Qiheng Yan, et al.
Frontiers in Immunology
|
February 26, 2024
Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study
Hongyu Wang, Huijie Huang, Ting Liu, et al.
Hepatology International
|
May 8, 2024
Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis
Yangyang Li, Jiandong Guo, Wendao Liu, et al.
La Radiologia Medica
|
October 6, 2023
A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy
Xuelei He, Kai Li, Ran Wei, et al.
International Journal of Surgery (London, England)
|
September 24, 2025
Identification and validation of an explainable machine learning model for hepatocellular carcinoma with high-risk: a retrospective multicenter cohort study
Shufang Hao, Xiaoyu Liang, Xue Li, et al.
Journal of Translational Medicine
|
June 19, 2026
Resveratrol derivative restores macrophage cholesterol homeostasis via stabilizing xanthine oxidoreductase in hepatocellular carcinoma
Guojun Liang, Lin Zeng, Xiaohui Huang, et al.
British Journal of Cancer
|
July 6, 2024
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study
Chao An, Ran Wei, Wendao Liu, et al.
International Journal of Surgery (London, England)
|
December 17, 2025
Resection versus microwave ablation following conversion therapy for unresectable hepatocellular carcinoma
Hanyu Jiang, Mengxuan Zuo, Ran Wei, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Cancer Medicine
|
January 10, 2024
Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis
Yangyang Li, Wendao Liu, Junwei Chen, et al.
Journal of Hepatocellular Carcinoma
|
July 13, 2026
SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling
Hongyu Wang, Guojun Liang, Ting Liu, et al.
Genes
|
July 27, 2022
Drug-Target Network Study Reveals the Core Target-Protein Interactions of Various COVID-19 Treatments
Yulin Dai, Hui Yu, Qiheng Yan, et al.
Frontiers in Immunology
|
February 26, 2024
Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study
Hongyu Wang, Huijie Huang, Ting Liu, et al.
Hepatology International
|
May 8, 2024
Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis
Yangyang Li, Jiandong Guo, Wendao Liu, et al.
La Radiologia Medica
|
October 6, 2023
A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy
Xuelei He, Kai Li, Ran Wei, et al.
International Journal of Surgery (London, England)
|
September 24, 2025
Identification and validation of an explainable machine learning model for hepatocellular carcinoma with high-risk: a retrospective multicenter cohort study
Shufang Hao, Xiaoyu Liang, Xue Li, et al.
Journal of Translational Medicine
|
June 19, 2026
Resveratrol derivative restores macrophage cholesterol homeostasis via stabilizing xanthine oxidoreductase in hepatocellular carcinoma
Guojun Liang, Lin Zeng, Xiaohui Huang, et al.
British Journal of Cancer
|
July 6, 2024
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study
Chao An, Ran Wei, Wendao Liu, et al.
International Journal of Surgery (London, England)
|
December 17, 2025
Resection versus microwave ablation following conversion therapy for unresectable hepatocellular carcinoma
Hanyu Jiang, Mengxuan Zuo, Ran Wei, et al.
Page
of 4